Gri bio bolsters intellectual property portfolio with granting of two global patents for europe and japan

Company committed to building a robust global patent estate across its innovative pipeline of nkt cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases

GRI Ratings Summary

GRI Quant Ranking